residues in the same domain of a protein can result in disparate functional consequences. It remains unclear exactly why these divergent mutations in the MATH domain interact differently with the BET proteins and other substrates. Could this be true for other adaptor proteins mutated in cancer? Further research providing structural insights to explain this important finding are now required. Importantly, as we near the completion of a comprehensive annotation of coding mutations in cancer, these findings dispel the assumption that all mutations within a functional domain have the same biological consequence. This highlights the importance of careful functional characterization for the vast catalog of mutations in cancer.
One potential implication of these data is that the rate-limiting step for the efficacy of BET inhibition in SPOP-mutant prostate cancer is the expression level of BET proteins. A key question here is what are the functional consequences of increased levels of BET proteins? Do they simply continue to facilitate the same transcription programs involved in maintaining SPOP-wild-type prostate cancer, or do they instead establish an alternative geneexpression program?
Interestingly, although Zhang et al. 6 also find that SPOP-mutant prostate cancer cells are relatively impervious to BET inhibition, they suggest that this resistance is independent of the AR, as well as the established BET target gene, MYC. By analyzing differential gene expression in isogenic cells expressing wild-type SPOP or a F133V-SPOP mutant, the authors uncovered BRD4-dependent upregulation of cholesterol biosynthesis and AKT and mTORC1 activation in SPOP-mutated cells. They demonstrate the potential therapeutic application of these findings by showing that AKT inhibition alleviates BET-inhibitor resistance in SPOP-mutated prostate cancer.
Similarly to Dai et al. 5 and Zhang et al. 6 , Janouskova et al. 7 observe that SPOP mutations lead to impaired degradation of BET proteins and reduced sensitivity to BET inhibitors in prostate cancer. Intriguingly, however, Janouskova et al. 7 show that endometrial cancer-specific SPOP mutations confer increased susceptibility to BET inhibitors, owing to accelerated degradation of BET proteins by SPOP. Remarkably, although BET proteins were more rapidly degraded in the context of endometrial SPOP mutations, this was not true for all SPOP substrates. Substrates with known oncogenic function, including TRIM24, DAXX, and NCOA3, were less efficiently degraded by SPOP containing endometrial cancer-associated mutations, akin to the findings with SPOP mutations in prostate cancer. This observation is likely to be important, because the gene-expression programs altered by prostate and endometrial cancer SPOP mutations in an isogenic background do not simply lead to quantitative variations in the same genes. In line with this, BET protein levels alone may not be the only relevant biomarkers predicting response and resistance to BET inhibitors, or indeed, other therapies in these malignancies. How the levels of other SPOP substrates influence sensitivity to conventional therapies in these cancers will be an important area of future research.
One of the most notable findings to arise from these studies is that cancer-specific mutations occurring at different amino acid
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A recent study reveals sexually dimorphic disease-associated gene-expression modules and hub genes in postmortem brains from female and male individuals with depression. These modules are conserved in mouse models of depression.
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Depression is a widespread, debilitating illness that is the leading cause of disability worldwide 1 . Rates of depression are two-to three-fold greater in women than in men, and previous studies conducted over past decades have reported differences in neurotransmitter, endocrine, and metabolic systems that could contribute to sex differences in mood susceptibility [2] [3] [4] [5] . Despite these efforts, the heterogeneity of depression and the problems inherent in identifying illness-related gene variants have made it difficult to identify the molecular and neurobiological bases of depression, particularly, the greater incidence of the condition in women. In this issue, Labonté et al. 6 use a bioinformatics approach 7, 8 to demonstrate that depression is characterized by different disease-associated gene modules in the postmortem brains of women relative to those in men, and that these modules are conserved in mice. The findings define for the first time the notable sexually dimorphic gene-expression networks in key brain regions that are implicated in depression, and so will help to elucidate the pathophysiology of and potential avenues for treating depression, particularly in women.
The authors analyzed gene-expression patterns in postmortem tissue from a total of 48 people in an initial cohort of female and male control individuals and those affected by major depressive disorder (MDD). Their study included analysis of tissue from six different brain regions implicated in depression: prefrontal cortical (PFC) subregions (ventromedial PFC (vmPFC), dorsolateral PFC, and orbital frontal PFC), anterior insula, nucleus accumbens, and ventral subiculum. They found sexual dimorphism in the levels of differentially expressed genes (DEGs) in brains from individuals with depression as compared to those from controls (with only a 5-10% overlap in differentially expressed genes between females and males with depression). Furthermore, there were sex differences in the regulation of interconnected gene networks that were conserved across brain regions in females and males with MDD. These findings were largely confirmed in a second cohort (50 additional female and male individuals, both control and with MDD), a major strength of this work. Further analysis of gene networks across brain regions identified sex-and volume 23 | number 9 | september 2017 nature medicine
To study the functional impact of these gender-specific depression modules and hubs, the authors turned to a mouse model of depression 9, 10 , in which chronic variable stress (CVS) exposure for 21 d produces depressionlike behavior, including increased anxiety and anhedonia, both of which are core symptoms of depression. The fact that CVS produces similar levels of depressive behaviors in both males and females demonstrates a limitation of this model. Nevertheless, transcript analysis in the Labonté et al. 6 study shows very low overlap of DEGs (20-25%) between female and male mice exposed to CVS in the two brain regions examined (the vmPFC and basis of the number of interconnecting DEGs across brain regions, is enriched for MAPK activity and is composed of 18 genes, four of which are hubs with multiple downregulated genes, as compared to controls, in multiple brain regions. In males with depression, one of the most highly ranked modules is enriched in genes associated with synaptic transmission; this module is composed of 311 genes, of which 43 are hubs with many upregulated transcripts, particularly in the vmPFC. The results suggest that these modules are subjected to sex-specific gene regulation that is distinctly associated with depression in each sex. depression-specific disease modules, with low levels of homology between brain regions in females and males. For example, of the 55 male-specific depression-associated gene modules, only ten showed conserved connectivity in females. Women and men also showed differential enrichment of depression-associated modules that are specific to different cell types and cell-specific functions.
Network analysis was also used to identify key sex-specific hub genes that are highly connected to multiple DEGs in and between disease modules and across different brain regions. In females with depression, one of the most highly ranked modules, on the Figure 1 Sex-specific gene-expression modules in depression. Schematic for the analysis of gender-specific depression-related modules in individuals with MDD and stressed mice. RNA-seq analysis was conducted on the indicated regions of the postmortem brains of women and men with depression and those of controls, and on female and male mice exposed to chronic variable stress. Network analysis reveals sex-specific networks across brain regions and identifies disease-related gene modules in women and men that overlap with chronic-stress-related modules in female and male mice. Manipulation of key hub genes in the top-ranked expression modules (decreased Dusp1 in female mice and increased Emx1 in male mice) produces convergent effects on neuronal activity in vmPFC and causes depressive behaviors, but only when these genes are manipulated in the corresponding female or male mice. OFC, orbital frontal cortex; NAc, nucleus accumbens; aINS, anterior insula; vSub, ventral subiculum; dlPFC, dorsolateral prefrontal cortex; vmPFC, ventromedial prefrontal cortex.
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Chronic-variable-stress model of depression Debbie Maizels/Springer Nature observed in women as compared to men? Importantly, what accounts for the development and the expression of gender-specific gene modules? Are these differences determined early in life by environmental, epigenetic, or X-linked genetic factors; later in life by endocrine and metabolic fluctuations; or by a combination of these factors across the life span? Are there other psychiatric illnesses that are also characterized by sex-specific modules?
The current study provides a wealth of information that can be used by others in the field, and that opens the door for future studies to address these and other questions about sexually dimorphic determinants of complex behaviors that could lead to more informed treatment strategies and cures for depression.
nucleus accumbens). Importantly, the results also show substantial overlap of DEGs, modules, and hub genes in female mice exposed to CVS as compared to women with depression, as well as in male mice exposed to CVS relative to men with depression (for example, in the vmPFC, there are 251 up-or downregulated transcripts conserved in females, and 152 in males), demonstrating that the CVSexposed mouse is a valid model system. The authors' findings in humans show that DUSP6, a protein phosphatase that inactivates ERK signaling, is a highly interconnected hub gene that is decreased in the vmPFC of females with depression, as is Dusp6 in mice exposed to CVS. In men with depression, the authors identified a different module and highly connected hub gene, the transcription factor EMX1, which regulates the development of cortical neurons, that is increased in vmPFC of males with depression and CVS mice. In female mice, a reduction in Dusp6 expression in the vmPFC was sufficient to increase susceptibility to depressive behaviors, such as increased latency before feeding and decreased sucrose preference, but male mice with reduced expression of this gene in the vmPFC had no discernible changes in behavior. Furthermore, these mice also had gene-transcript alterations that overlapped with the changes caused by CVS, which provides evidence that this hub gene is a key regulator of multiple, connected genes and depression-associated modules. Conversely, overexpression of EMX1 in the vmPFC reproduced some, but not all, of the depressive behaviors in males, such as increased anxiety but not anhedonia, which indicates that other hub genes are involved in the development of depressive behaviors in males. Importantly, overexpression of Emx1 in the vmPFC of female mice had no effect on their behavior. Finally, decreased DUSP6 or increased EMX1 expression resulted in elevated activity of vmPFC pyramidal neurons in females and males, respectively, demonstrating a functional convergence of these two hub genes that could underlie the similar behavioral deficits observed in both sexes.
The demonstration of sex-specific, functional illness-related gene modules represents a major advance for the field of depression. It will be interesting to confirm these findings in additional postmortem cohorts of females and males with MDD, as well as in other mouse models of depression. These findings also raise many more questions regarding illness modules in other brain regions implicated in depression (such as the hippocampus and amygdala). For example, a previous study reported increased expression of a related gene, DUSP1, in the hippocampus of individuals with depression, and the expression of Dusp1 was necessary and sufficient to cause depression in male rodents 11 ; females were not tested. What is the functional impact of this and other hub genes and modules in vmPFC and other brain regions? Additionally, which of these modules accounts for the higher rates of depression
